Latest News About Hiscox Société Anonyme

Here’s a quick update on Hiscox Société Anonyme (HSA) and related Hiscox entities. If you want, I can pull fresh sources and summarize more precisely.

• What is Hiscox Société Anonyme (HSA)?

  • Hiscox Société Anonyme is the Luxembourg-based insurance subsidiary of the Hiscox Group, reporting under Solvency II and delivering local financial results in line with Luxembourg regulatory requirements. This entity is part of Hiscox’s international insurance operations and contributes to the group’s profitability and capital management.[2]

• Recent regulatory and financial highlights (as reported around 2023–2024):

  • HSA posted underwriting profitability in 2023 with a result of €2.2 million and a combined ratio of 93% (down from 96% in 2022), indicating improved underwriting discipline, though profitability remained modest.[2]
  • The group’s Solvency II own funds were reported at €107.1 million with an SCR of €69.3 million, yielding an SCR coverage of 155%, and MCR of €31.2 million at year-end 2023, reflecting a solid capital position for HSA within the Luxembourg framework.[2]
  • There were no dividends declared for the 2023 year in line with some insurers’ capital preservation stance; prior periods also show nil dividends for those Luxembourg reports.[2]
  • Operational expenses remained controlled, with an expense ratio around 19% (up slightly from 18% in 2022) as management pursued growth initiatives and cost containment.[2]

• Group-level and latest public statements (as of 2025–2026):

  • Hiscox Group has issued multiple trading updates and press releases indicating robust performance in 2025 and early 2026, including record profits, attractive cash returns to shareholders, and ongoing capital management activities (e.g., buybacks and dividends) across the group.[4][5]
  • The group’s 2025 full-year results and Q1 2026 trading statements reflect continued premium growth, strong underwriting discipline, and strategic partnerships to expand in adjacent markets, with a focus on risk selection and portfolio balance.[5][4]
  • The Luxembourg and other local regulatory disclosures (e.g., Solvency and Financial Condition Reports) remain publicly available and show how HSA interfaces with the broader group capital framework and governance standards.[6]

• Context for investors and researchers:

  • HSA is one piece of Hiscox’s broader international insurer portfolio, contributing to diversification across jurisdictions and products. Its capital position (SCR coverage) and underwriting efficiency are useful indicators of how the Luxembourg entity supports the group’s overall risk capacity and profitability targets.[2]
  • For up-to-date specifics such as latest quarterly numbers, dividend announcements, or any material regulatory events affecting HSA, refer to Hiscox’s Luxembourg solvency disclosures and the Hiscox Group press room and regulatory announcements.[7][4][6]

Illustrative note:

• If you want a quick snapshot table (2023 vs 2022 underwriting results, SCR coverage, and MCR) I can generate one. For now, the key takeaway is that HSA posted positive underwriting results in 2023, maintained a strong capital position under Solvency II, and aligned its dividend policy with capital maintenance.

Would you like me to fetch the latest Luxembourg SFCR and summarise any new figures or provide a concise table comparing HSA with the broader Hiscox group for the latest available year? I can also pull the most recent press release or regulator filing and provide direct citations.